Cargando…
DNA aptamer S11e recognizes fibrosarcoma and acts as a tumor suppressor
Fibrosarcoma is a serious malignant mesenchymal tumor with strong invasiveness, high recurrence, and poor prognosis. Currently, surgical resection is the main treatment for fibrosarcoma. However, due to the lack of specific biomarkers, the inability to accurately diagnose fibrosarcoma can lead to su...
Autores principales: | Liu, Yunyi, Peng, Cheng, Zhang, Hui, Li, Juan, Ou, Hailong, Sun, Yang, Wen, Chaoqi, Qi, Dan, Hu, Xiaoxiao, Wu, Erxi, Tan, Weihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897059/ https://www.ncbi.nlm.nih.gov/pubmed/35310383 http://dx.doi.org/10.1016/j.bioactmat.2021.10.011 |
Ejemplares similares
-
Identification of new aptamer BC-3 targeting RPS7 from rapid screening for bladder carcinoma
por: Liu, Yunyi, et al.
Publicado: (2022) -
Rituximab-specific DNA aptamers are able to selectively recognize heat-treated antibodies
por: Kohlberger, Michael, et al.
Publicado: (2020) -
DNA Aptamers as Molecular Probes for Colorectal Cancer Study
por: Sefah, Kwame, et al.
Publicado: (2010) -
Induction of tolerance to a murine fibrosarcoma in two zones of dosage--the involvement of suppressor cells.
por: McBride, W. H., et al.
Publicado: (1986) -
Selection and characterization of DNA aptamer against glucagon receptor by cell-SELEX
por: Wang, Guodong, et al.
Publicado: (2017)